News
Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...
A year-long clinical trial has found that Ambroxol, a cough syrup commonly sold across Europe, could potentially slow the ...
The AI tool, StateViewer, helped researchers identify a person’s dementia type in 88% of cases, according to results newly ...
A COMMON cough medicine could help protect people with Parkinson’s against dementia. Around 145,000 people in the UK have ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...
New research finds that diet, exercise, and stress management helped improve or stabilize brain function in early-stage ...
A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...
Research study in London shows a common cough medicine as a potential treatment to slow dementia, reports CTV London’s Reta ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...
Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...
A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results